Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Ocular Hypertension- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Ocular ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023
... Breast Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights ... Read More
-
Ewing Sarcoma Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Infoposide, Dactinomycin); By Treatment; By Application; By Region; Segment Forecast, 2023 - 2032
... market size is expected treach USD 424.42 million by 2032, according ta new study by Polaris Market Research. The report “Ewing Syndrome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Vincristine, Cyclophosphamide, ... Read More
-
Guillain-Barre Syndrome- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Guillain-Barre ... Read More
-
Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2023
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Dry Age-related Macular Degeneration- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Delayed Onset Type 1 Diabetes
... a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review ... Read More
-
Alzheimer'S Disease Diagnostics And Therapeutics Market - Growth, Trends And Forecasts (2023 - 2028)
... USD 9,639.23 million at the end of the forecast period, registering a growth with CAGR of 5.51% over the forecast period. The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, ... Read More
-
Custom Antibody Market by Service (Development, Purification, Labelling), Type (Monoclonal, Recombinant), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology), End User (Biopharma, CROs) - Global Forecast to 2028
... is projected to reach USD 860 million by 2028 from USD 548 million in 2023, at a CAGR of 9.4% during the forecast period. Factors such as increasing investment for the development of ADCs and ... Read More
-
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031
... inflammation usually begins in the rectum and lower colon, but may also spread continuously to involve the entire colon. In UC, ulcers develop on the surface of the bowel lining; these may bleed and produce ... Read More
-
Australia & New Zealand Healthcare CROs Market Size, Share & Trends Analysis Report By Phase Type (Drug Discovery, Preclinical, Clinical), By Service, By Application, By End-use, By Country, And Segment Forecasts, 2023 - 2030
... & New Zealand Healthcare CROs Market Growth & Trends The Australia & New Zealand healthcare CROs market size is expected to reach USD 2.4 billion by 2030, according to a new report by Grand View ... Read More
-
Essential Tremor (ET) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6,000,000 diagnosed prevalent cases of ET in 2023 in the 16 major markets. The marketed drugs space for ET is widely genericized and is dominated by beta-blockers and anticonvulsants. R&D activity in ET is very ... Read More
-
Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Cellulitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulitis. Report includes ... Read More
-
Global Label-free Array Systems Market Size study & Forecast, by Technology (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy, and Other Technologies), Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Development, Protein Complex and Cascade Analysis, Other Applications), End User (Contract Research Organizations, Agricultural Research Institutes, R&D Laboratories, Other End Users), and Regional Analysis, 2022-2029
... Cascade Analysis, Other Applications), End User (Contract Research Organizations, Agricultural Research Institutes, R&D Laboratories, Other End Users), and Regional Analysis, 2022-2029 The global Label-free Array Systems Market is valued at approximately USD XX billion in ... Read More
-
Global Bleeding Disorders Treatment Market Size study & Forecast, by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), by Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Bleeding Disorders Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
Global Multiple Sclerosis Drugs Market Size study & Forecast, by Drug Class (Immunomodulators, Immunosuppressants, Interferons) by Route of Administration (Oral, Injection), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029
... Multiple Sclerosis Drugs Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Multiple sclerosis is an ... Read More
-
U.S. Medical Foods For Orphan Disease Market Size, Share & Trends Analysis Report By Route Of Administration, By Product, By Application, By Sales Channel, And Segment Forecasts, 2023 - 2030
... Disease Market Growth & Trends The U.S. medical foods for orphan disease market is expected to reach USD 527.5 million by 2030, expanding at a CAGR of 5.6% from 2023 to 2030, based on a ... Read More
-
Gouty Arthritis (Gout) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pre-clinical and clinical stage pipeline candidates under development as of H1- 2023. For each of the Gouty Arthritis (Gout) pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule ... Read More
-
Insomnia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... pipeline candidates under development as of H1- 2023. For each of the Insomnia pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other critical information is ... Read More
-
Japanese Encephalitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Japanese Encephalitis pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Fabry Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Fabry Disease pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Celiac Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Celiac Disease pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Eosinophilic Esophagitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Eosinophilic Esophagitis pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Gaucher Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Gaucher Disease pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
Research Assistance
